polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Associations were observed between (a) p53 wild type status and upregulation of some TP73 variants; (b) overexpression of E2F-1 and some TP73 forms; and (c) upregulation of DeltaTAp73 variants and advanced pathologic stage, lymph node metastasis, vascular invasion, presence of polyps, and tumor localization.
|
16380414 |
2006 |
polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Multivariate analysis showed that previous history of a polyp (P = 0.03) was inversely associated with p53 overexpression.
|
16896030 |
2006 |
polyps
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Defects in MIB-1 proliferation indices and p53 were not significantly different among the same epithelial components in each of the polyp groups.
|
15712188 |
2005 |
polyps
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Immunohistochemical patterns of p53 and beta catenin were studied using the natural carcinogenetic model of malignant colorectal sporadic adenoma in 27 formalin-fixed paraffin-embedded polyps.
|
12871177 |
2003 |
polyps
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Although p53 positivity and aneuploidy were correlated with invasiveness of carcinoma in the index polyp (P = 0.025), Adnab-9 positivity was not.
|
12645814 |
2003 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Additional and new K-ras mutations were also induced in two polyps in which K-ras mutation had pre-existed. p53 mutations were not observed in both MNNG-treated and untreated groups.
|
12048157 |
2002 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
In this study, we retrospectively evaluated whether telomerase activity and p53 gene mutations are useful parameters for detecting malignant changes in polyps in patients with FAP.
|
11268463 |
2001 |
polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
LOH at 17p was not seen in polyps or carcinomas; immunohistochemistry showed expression of p53 in one carcinoma and focal expression in three polyps.
|
11215281 |
2001 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
We detected p53 mutations in the primary polyp, even in the cut end of the polyp.
|
11480796 |
2001 |
polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Hyper-plastic polyp showed an increased p21 and p53 expression with no bcl2 expression.
|
9651943 |
1998 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
A low rate of p53 mutations was detected in HCL and polyps.
|
9628350 |
1998 |
polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
DNA sequence alterations in p53 were not found, although high p53 protein levels could be shown by immunohistochemistry in areas of carcinoma within the largest polyp.
|
9024310 |
1997 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Patient sex, polyp location, size, degree of atypia, or p53 mutation did not affect the response, but polyps in older patients were more sensitive to sulindac.
|
9135523 |
1997 |
polyps
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Weak p53 expression was demonstrated by 11.7% of the flat hyperplastic polyps but none of the exophytic polyps reacted.
|
7559739 |
1995 |
polyps
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The presence of both p53 overexpression and K-ras mutation in a benign tubulovillous polyp in the present series suggests that in vivo this combination of events is insufficient to cause malignant transformation of a large bowel adenoma.
|
8504962 |
1993 |